Liefke C. van der Heijden

发表

Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary Angiography: The International Multicenter FAVOR Pilot Study.

J. Reiber, A. Lansky, C. von Birgelen, 2016, JACC. Cardiovascular interventions.

Two-year outcome after treatment of severely calcified lesions with newer-generation drug-eluting stents in acute coronary syndromes: A patient-level pooled analysis from TWENTE and DUTCH PEERS.

Maarten J. IJzerman, C. von Birgelen, G. Linssen, 2017, Journal of cardiology.

Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial

Maarten J. IJzerman, J. W. Louwerenburg, C. von Birgelen, 2016, Heart and Vessels.

Impact of severe lesion calcification on clinical outcome of patients with stable angina, treated with newer generation permanent polymer-coated drug-eluting stents: A patient-level pooled analysis from TWENTE and DUTCH PEERS (TWENTE II).

Maarten J. IJzerman, M. Stoel, C. von Birgelen, 2016, American heart journal.

Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents

M. Stoel, C. von Birgelen, G. Linssen, 2018, Journal of the American Heart Association.

High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial

C. von Birgelen, G. Linssen, C. Schotborgh, 2018, Cardiovascular Drugs and Therapy.

Coronary bifurcations treated with thin-strut drug-eluting stents: a prespecified analysis of the randomized BIO-RESORT trial.

C. von Birgelen, G. Linssen, C. Schotborgh, 2021, Coronary artery disease.

Serial assessment of endothelial function 1, 6, and 12 months after ST-elevation myocardial infarction

R. Peters, C. von Birgelen, Liefke C. van der Heijden, 2018, Heart and vessels.

Five-Year Outcome After Implantation of Zotarolimus- and Everolimus-Eluting Stents in Randomized Trial Participants and Nonenrolled Eligible Patients: A Secondary Analysis of a Randomized Clinical Trial

M. Stoel, C. von Birgelen, G. Linssen, 2017, JAMA cardiology.

Small Vessel Coronary Artery Disease: Rationale for Standardized Definition and Critical Appraisal of the Literature

C. von Birgelen, M. Chiarito, H. Garcia-Garcia, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT.

J. W. Louwerenburg, M. Stoel, I. Knottnerus, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT.

J. W. Louwerenburg, M. Stoel, I. Knottnerus, 2018, International journal of cardiology.

Reply to Letter to the Editor entitled: "Bioresorbable stent thrombosis, lactic acid release and Kounis syndrome".

C. von Birgelen, Liefke C. van der Heijden, B. Mukete, 2017, International journal of cardiology.

Clinical outcomes after percutaneous coronary intervention with the COMBO stent versus Resolute Integrity and PROMUS Element stents: a propensity-matched analysis.

M. Beijk, P. Woudstra, J. Tijssen, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial.

C. von Birgelen, G. Linssen, F. de Man, 2015, American heart journal.

Three-Year Clinical Outcome of Patients with Coronary Disease and Increased Event Risk Treated with Newer-Generation Drug-Eluting Stents: From the Randomized DUTCH PEERS Trial

M. Stoel, C. von Birgelen, G. Linssen, 2017, Cardiology.

Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial

Maarten J. IJzerman, C. von Birgelen, G. Linssen, 2015, Clinical Research in Cardiology.